Wed, 07th Mar 2018 12:41
The warrants were exercised at a price of
Shares in N4 were 3.0% lower at
Admission of the new shares to trading on AIM is expected to take place on Thursday. After admission, N4 will have 89.1 million shares outstanding.
The warrant exercise follows a number of similar transactions in recent weeks.
(Alliance News) - N4 Pharma PLC on Thursday said it has entered into a collaboration agreement with SRI International Inc.
N4 Pharma PLC - Derbyshire, England-based pharmaceutical company focused on the development of Nuvec - Posts revenue of GBP1,953 in 2023, compared to ...
(Alliance News) - N4 Pharma PLC on Thursday reported that its novel delivery system for cancer treatment has shown promise, after a successful trial.
(Sharecast News) - N4 Pharma announced a significant advancement in the development of Nuvec, an innovative delivery system tailored for cancer treatm...
N4 Pharma Plc (N4P)